Skip to content
The Nexus
BUSINESSJul 21 · 11:35 UTCCNBC TOP

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Novo Nordisk has filed a lawsuit against Eli Lilly, accusing the company of running misleading GLP-1 advertisements. The lawsuit seeks to halt these ads and mandate corrective advertising.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting